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ABSTRACT
Alternative splicing, polyadenylation of pre-
messenger RNA molecules and differential
promoter usage can produce a variety of transcript
isoforms whose respective expression levels are
regulated in time and space, thus contributing
specific biological functions. However, the rep-
ertoire of mammalian alternative transcripts
and their regulation are still poorly understood.
Second-generation sequencing is now opening
unprecedented routes to address the analysis of
entire transcriptomes. Here, we developed
methods that allow the prediction and quantification
of alternative isoforms derived solely from exon
expression levels in RNA-Seq data. These are
based on an explicit statistical model and enable
the prediction of alternative isoforms within or
between conditions using any known gene annota-
tion, as well as the relative quantification of known
transcript structures. Applying these methods to a
human RNA-Seq dataset, we validated a significant
fraction of the predictions by RT-PCR. Data further
showed that these predictions correlated well with
information originating from junction reads. A direct
comparison with exon arrays indicated improved
performances of RNA-Seq over microarrays in
the prediction of skipped exons. Altogether, the
set of methods presented here comprehensively
addresses multiple aspects of alternative
isoform analysis. The software is available as an
open-source R-package called Solas at http://cmb
.molgen.mpg.de/2ndGenerationSequencing/Solas/.
INTRODUCTION
Alternative splicing (AS) is the mechanism by which
a common precursor mRNA produces diﬀerent
mRNA variants, by extending, shortening, skipping, or
including exon, or retaining intron sequences.
The combinatorics of such AS events generates a large
variability at the post-transcriptional level accounting
for an organism’s proteome complexity (1,2). Besides
AS, other biological mechanisms shape the trans-
criptome, like alternative ﬁrst or last exon usage or alter-
native polyadenylation of exons (3,4). Altogether, these
events are summarized as alternative exon events
(AEEs). Various gene isoforms generated by AEEs have
speciﬁc roles in particular cell compartments, tissues,
stages of development, etc. In addition, many diseases
(e.g. cancer) have been related to alterations in the
splicing machinery, highlighting the relevance of AS to
therapy (5–7).
It has been previously estimated that 75–92% of all
human genes give rise to multiple transcripts (8–10). Up
to now, systematic analysis of alternative isoforms was
based on the analysis of expressed sequence tags (ESTs),
or on microarray experiments. ESTs have been initially
used for the detection and prediction of alternative
splice forms in diﬀerent organisms and cell types
(1,11–13). However, this approach showed inherent
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transcript coverage and low abundance for individual
tissues (11,14). More recently, alternative isoforms have
been analysed by microarrays using exon body probes
(exon arrays) and/or probes spanning splice junctions
(exon junction arrays) (8,12,15–17). Custom arrays,
combining exon body and splice junction probes have
been used for quantifying isoform expression levels (18).
In parallel, the standard platform provided by the
Aﬀymetrix human exon array allows the monitoring of
10
6 exons derived from 18000 known genes and approx-
imately 262000 predicted transcripts (19). However,
several problems inherent to the use of arrays, such as
probe hybridization behaviour, cross hybridization of
related probes and deconvoluting signal-to-noise ratios
(14) are diﬃcult to overcome. For instance, for the
human Aﬀymetrix exon arrays, the validation rate
ranges from 33% (20) to 86% (19). Besides, the
computational analysis of exon arrays remains a
complex task (21,22).
Second-generation sequencing represents an invaluable
advance for analysing the transcriptome and the repertoire
of AEEs. RNA-Seq experiments provide in-depth infor-
mation on the transcriptional landscape with unprece-
dented sensitivity and throughput (23–30). RNA-Seq
data allow the direct detection of AS events using the
reads mapping at splice junctions, specifying both
known as well as novel AS forms (9,10). However, a com-
prehensive survey of AS by junction reads is intrinsically
dependent on the sequencing depth. Typical sequencing
depths with one or two lanes might only provide reads
specifying approximately half of the exon–exon junctions
occurring within a cell.
Here, we provide a set of methods that enable the detec-
tion and quantiﬁcation of AEEs within or between condi-
tions using a given gene annotation. The Cell type-speciﬁc
Alternative uSage Index (CASI) predicts AEEs within a
given condition, e.g. one cell line. The PrOportion
EstiMation method (POEM) enables the relative quantiﬁ-
cation of known transcript structures within a given con-
dition. Finally, the Diﬀerential Alternative uSage Index
(DASI) predicts AEEs diﬀerentiating two conditions,
e.g. between two cell lines.
All methods are based on a stochastic model of the read
distribution along a transcript and show high robustness
based on simulations. We applied the methods on a
previously published RNA-Seq dataset from two human
cell lines (27). We predicted several thousands of AEEs
and estimated isoform abundance for suﬃciently
expressed genes. Further, we validated our predictions
and estimations by RT-PCR experiments on more than
100 cases. The robustness of the methods was additionally
assessed by bootstrapping.
We report the ﬁrst comparison of splicing prediction by
RNA-Seq and exon arrays, showing that RNA-Seq is
more sensitive and estimates exon expression values with
higher accuracy. In summary, we provide a versatile and
reliable set of tools that covers multiple aspects of alter-
native isoform analysis, which is available as an
open-source package called Solas at http://cmb.molgen
.mpg.de/2ndGenerationSequencing/Solas/.
MATERIALS AND METHODS
Transcript sampling model
All reads from an RNA-Seq experiment are of the same
length r (usually around 30–36bp). Due to the nature of
the RNA-Seq protocol, which involves random shearing
of the messenger RNA molecules, we consider that the set
of sequenced fragments is picked randomly out of a bag of
transcript positions. First, the total number of reads
T covering a gene is determined by a Poisson process:
T   Poissonð    s   pÞ, where s is the total length of
the gene, p is the relative proportion and l is a normalizing
factor related to sampling depth. The Poisson framework
suits especially for low-coverage datasets, where a normal
distribution cannot serve as a good approximation (31).
This model has already been proposed for abundance of
EST data (32), as well as SAGE libraries (33). For ease of
notation, the approach is described for one gene, but all
formulas can be extended for a set of genes.
Due to the hypothesis that the reads are positioned
randomly along every transcript, the number of
observed reads within exons Y ¼ð YeÞe¼1::n is drawn
according to a multinomial distribution Mð pe ðÞ
n
e¼1,TÞ.
The probability pe that a read falls in exon e is
parameterized for every gene according to the properties
of the RNA-Seq experiment. An obvious parameter for pe
is the eﬀective length le of an exon. The eﬀective exon
length corrects for exonic regions where reads of length
r cannot be uniquely mapped due to highly homologous
gene families, pseudogenes and low sequence complexity.
Any other information aﬀecting the read coverage—such
as GC bias or a bias speciﬁc to the protocol used—can be
included in the deﬁnition of eﬀective exon length. Finally,
we deﬁne the normalized expression ~ ye of an exon e as the
exon read count normalized by the exon relative propor-
tion and the gene size:
~ ye ¼
ye
pe   s
ð1Þ
We ﬁrst provide a test framework to detect AEEs
occurring within a given cell type (CASI method) or
related to the presence of diﬀerent isoform patterns
between two cell types (DASI method). In both cases, a
two-step procedure was applied, which (i) detects genes
with AEEs based on CASI and DASI p-values and (ii)
highlights exons predicted to be alternative according to
a z-score statistic. The z-score statistic is computed for
each exon e as:
ze ¼
Re   medianðR Þ
MADðR Þ
ð2Þ
where R is deﬁned according to each exon log normalized
expression or expression ratio (see below). We use the
median and maximum absolute deviation (MAD) as
robust estimates of mean and standard deviation to
avoid a bias for genes with few exons. This statistics
assumes that the majority of the exons are constitutive.
Alternative exon usage within a condition (CASI)
Under the null hypothesis that one transcript uses all the
exons of the gene, the counts within exons follow a
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AEEs within a condition was assessed by using
Pearson’s chi-square test on Mp e ðÞ
n
e¼1,T
  
, where the
p-value was corrected for multiple testing using the
Benjamini–Hochberg procedure (34). Only genes with at
least two expressed exons were tested. A gene with a small
CASI p-value means either that (i) two or more transcripts
from one gene are present or (ii) one isoform is present but
only a subpart of one of its exons is expressed. Case
(ii) can correspond to events of alternative donor
or acceptor sites, where only a part of the exon is
expressed. The zC score (CASI) is computed for each
exon, according to its log-normalized expression
RC
e =log(~ ye). Exons with less than ﬁve counts were not
considered for CASI computation. The CASI p-value was
set to 0.05.
Alternative exon usage between two conditions (DASI)
Two observed read distributions y and z were consid-
ered for the same gene in two diﬀerent experiments.
The diﬀerence in exon usage pattern between the two
conditions was analysed for every gene conditionally
on its expression in both conditions. The presence of
diﬀerential AEEs was assessed with the FDR-corrected
p-value of Fisher’s exact test (34). Every exon e of the
gene was assigned a zD score (DASI) based on the
log-ratio RD
e ¼ logye=ze of reads between the two
experiments.
Exons with less than ﬁve read counts in both conditions
were not considered. A pseudo count of 1 was added to ye
and ze if its original value was 0. The DASI p-value was set
to 0.05 and the |DASI| 2. Genes showing a signiﬁcant
diﬀerence between the two biological replicates were
removed from the DASI analysis.
Quantiﬁcation of isoform levels (POEM)
Under the assumption that k diﬀerent transcript variants
with counts T1,...,Tk are expressed, the structure of each
transcript is given and described by the matrix of binary
values Ie,j, such that Ie,j ¼ 1 if form j uses exon e. The read
counts Ye in a single exon are the sum of all transcript
reads falling within the exon:
Ye ¼
X
j2isoforms
pe P
i
pi   Ii,j
  Ie,j   Tj ð3Þ
Substituting Ye and T by their expected values, unique
mean estimates of the Tj can be obtained by solving a
linear system, given that the matrix Ye is of full rank.
We employed an Expectation–Maximization (EM)
strategy for maximizing the likelihood and to infer the
unobserved transcript proportions. The counts Yj
e of
form j in exon e are fully described by the following hier-
archical model:
Tj   Poissonð jÞ with  j ¼    
1
P
i
pi   Ii,j
  qj ð4Þ
Y
j
1,Y
j
2,...,Yj
n
  
jTj ¼ mj   M
pe P
i
pi   Ii,j
  Ie,j
0
@
1
A
n
e¼1
,mj
0
B @
1
C A
8j ¼ 1,...,k
ð5Þ
where qj is the relative proportion of form j and   is a
normalizing factor accounting for the depth of sequencing
and the length of the transcript. Given the marginal
counts Ye ¼
Pk
j¼1 Yj
e, the aim is to infer the expected
counts for each exon per transcript. A condition of
identiﬁability for the parameters (and thus to
unambiguously identify the transcript proportions) is the
linear independence of the rows of the indicator matrix I
(35). An EM algorithm was used to estimate the propor-
tions of each form Pj. The EM update formulas and the
method to derive a quality score for each gene are
described in Supplementary Material.
The CASI analysis showed that large modiﬁcations are
occurring on the most 30-o r5 0-exons. We, therefore, spe-
ciﬁcally focused POEM estimation based on information
from internal exons, by artiﬁcially removing the ﬁrst and
last exon of every transcript before POEM estimation.
Simulations based on a gene model
In order to assess the accuracy for diﬀerent methods, we
simulated a single exon skipping event for a template gene
model. The inclusion rate of the exon as well as the length
of the skipped exon and the gene expression level varied.
Reads were drawn randomly along exons of the gene
according to the distribution introduced previously.
Noise was introduced in the model by choosing one
exon at random and artiﬁcially modifying the proportion
of reads mapping to it by 20%.
The simulations for CASI assumed a gene with six
exons and a length of 150bp per exon. We simulated dif-
ferent expression levels on two isoforms (proportion
0.05–0.95) such that the total read number in all exons
was 300. We evaluated the proportion of genes detected
by CASI where the skipped exon was properly ﬂagged as
an AEE (sensitivity) and the proportion of genes detected
where only the skipped exon was predicted as an AEE
(speciﬁcity). For diﬀerent levels of noise, we performed
500 simulations on 1000 genes.
The simulations for POEM assumed a gene of 1200-bp
length. We varied the length of the skipped exon (120, 240
and 360bp), the exon inclusion rate (20 and 80%) and the
gene expression level (100–600 reads) to assess their
impact on the estimation error rate. Two thousand simu-
lations were performed for each combination of the
parameters. Box plots are drawn according to the follow-
ing deﬁnition: the box describes 50% of the distribution,
the line displays the median and whiskers display the 1.5
interquartile range. Remaining outliers are shown as dots.
Simulations based on ENSEMBL transcripts
We performed a study on the database of annotated tran-
scripts (see below) to monitor the error on proportion
estimation with POEM as a function of gene expression.
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the relative proportions were incremented in steps of equal
size from 16.7% to 83.3% (10000 runs for each combina-
tion). The sampling of the transcripts was done hierarchi-
cally. First, a gene was chosen uniformly among all genes
annotated with more than two isoforms in ENSEMBL.
Then, two transcripts were uniformly sampled among
the annotated isoforms of the gene.
A bootstrap procedure for robustness assessment
Local nonhomogeneity of the read distribution along a
transcript could lead to false positive predictions.
Possible sources for an uneven read distribution along a
transcript are preferred break points of the RNA frag-
ments in the sample preparation step or a higher
sequencing eﬃciency for short cDNA fragments with
certain sequence characteristics (25,36). We ruled out
that such unevenness aﬀects our predictions by perform-
ing a bootstrap procedure for each gene.
For each bootstrap sample (total of 500), each exon of a
givengenewasrandomlypicked, withaprobabilityof0.25,
andshortenedononeendby5,10,15and20%.Onlyexons
with more than 80 unique positions were shortened. The
read count and the number of possible unique positions
were recomputed for each shortened exon and treated as
a new transcript annotation set. The prediction was
repeated on every new transcript annotation set.
Transcript and AEEs database construction
Annotation of transcript structures for POEM (i.e. the
indicator matrix I) was deduced from ENSEMBL,
version 46. To allow description of any possible isoform
(for instance, alternative donor and alternative acceptor
sites), exons overlapping with diﬀerent boundaries across
isoforms were further subdivided. Redundant transcripts
were ﬁltered out. Two transcripts were recursively clus-
tered when the sequence identity, relative to the mean
length of both transcripts, was at least 95%. A represen-
tative of each cluster was chosen by taking the union of
the corresponding rows in I. The number of genes with
identiﬁable transcripts was counted by computing the
rank of the indicator matrix (qr function in R).
The annotation of exon boundaries for CASI and
DASI, including the counting of nonunique positions
and treatment of overlapping genes, was done as
reported previously (27).
The set of genes with APSs was derived from EST data
taken from the GeneNest database (37) and was
independently screened for putative polyadenylation
signals (AAUAAA and AUUAAA). To generate a
high-conﬁdence set, only EST sequences annotated as
30-ends and aligned in the appropriate orientation were
selected. A reliable polyadenylation signal was deﬁned
when at least two ESTs carried a putative polyadenylation
signal within their 30-terminus (less than 35bp) at the same
position in the cDNA consensus sequence. Signals not
supported by the respective genomic sequence were
rejected.
The set of genes with alternative TSSs was derived from
EST consensus sequences that were mapped to the human
genome. For each ENSEMBL gene, only consensus
sequences covering at least two exons and with an exon
boundary quality  50 (11) were selected. The 50-termini of
mutually exclusive ﬁrst exons of these consensus sequences
were deﬁned as putative TSS.
Read alignment and splice junction annotation
Read sequences of length 27bp were retrieved from the
Gene Expression Omnibus database (GSE11892) and
aligned against HG18 with Eland from the Illumina
company allowing up to two substitution errors for a
match. Only unique read matches were retained.
Transcript annotation was based on all transcripts in
ENSEMBL version 46. Splice junction annotation was
derived by mapping reads as set of synthetical splice junc-
tions that were generated for all possible exon–exon junc-
tions for annotated exons of one gene [similar to (27)].
AEEs identiﬁed by splice junctions were deﬁned as
follows: each splice junction with a minimum support of
three reads was recorded and an exon that was span by
more than one such splice junction was ﬂagged as an AEE.
POEM validation
Reads mapping to splice junctions were used to directly
quantify AEEs by computing the proportion of reads
mapping to the constitutive junction. We averaged the
proportions deduced from both splice junction read
counts identifying the same AEE. An illustrative
example is shown in Figure 4, where the inclusion rate
of exon 5 (0.84) was calculated as the average of (i)
counts on junctions 4–5 and 4–6 [8/ (8+2)=0.8] and
(ii) counts on junctions 5–6 and 4–6 [14/ (14+2)=0.87].
For qPCR and POEM data comparison, POEM esti-
mates were derived for the skipped and constitutive forms
only, irrespective of other transcripts annotated in
ENSEMBL.
Sample preparation
The same source of total RNA from HEK and B cells was
isolated as described by Sultan et al. (27) and was used for
qPCR (DASI and POEM) experiments; the same source
of material and one biological replicate was used for exon
array hybridization experiments; an independent source of
total RNA from HEK and B cell was used for Reverse
Transcriptase Polymerase Chain Reaction (RT-PCR)
experiments (CASI).
RT
Reverse transcription was carried out using standard con-
ditions. In brief, 1mg of DNase-treated total RNA sample
was reverse-transcribed into ﬁrst-strand cDNA using
random hexamers and SuperscriptII reverse transcriptase
(Invitrogen) and subsequently diluted with nuclease-free
water (Promega) to 12.5ng/ml equivalent total RNA.
PCR
Ampliﬁcation parameters were as follows and were
adjusted according to the expected length of the
products and to the Tm of the primers: 95 C for 10min;
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for 30–120s, followed by extension at 72 C for 5min.
Reaction products were analysed by agarose gel
electrophoresis.
Quantitative PCR
Reactions were performed using the ABI Prism 7900HT
Sequence Detection System (PE Applied Biosystems) with
10ml reaction composed of 1/10 volume of the cDNAs
(prepared as described above), 300nM primers and
SYBR Green PCR Master Mix, containing SYBR
Green I Dye, AmpliTaq Gold DNA Polymerase, dNTPs
with dUTP, passive reference and optimized buﬀer
components (Applied Biosystems). Cycling conditions
were 50 C for 2min, 95 C for 10min followed by 40
cycles of 94 C for 15s and 60 C for 1min. Speciﬁcity of
PCR ampliﬁcation was veriﬁed by analysis of the melting
curve and subsequent electrophoresis on 4%
NuSieve:agarose (3:1) gel. Negative controls produced
negligible signal detection (38–40 Ct). All reactions were
performed in triplicates on 96-well plates. Ampliﬁcation
plots and predicted threshold cycle (Ct) values were
obtained with the Sequence Detector Software (SDS
version 2.0, PE Applied Biosystems). Further calculations
and graphical representations were done using Excel 2004
and R. A common threshold value was chosen for all
genes and the baseline was set manually for individual
genes. The relative expression calculation method relies
on the principle of the comparative Ct method
(User Bulletin #2; Applied Biosystems). Ct values were
ﬁrst normalized ( Ct) to the housekeeping genes
(GAPDH) and converted to a relative expression
quantity (NE) using the formula NE=2
  Ct. A given
S1/S2 ratio was calculated by dividing their respective
NE values.
Primer design for selected genes
All AEEs for CASI (61) were randomly selected among
all events annotated as internal exons with no overlapping
annotation for multiple exon skipping. We further selected
16 AEEs out of the highest scoring DASI genes (220),
from which we tested the exons exhibiting the maximal
absolute DASI. Overall, the major selection criterion for
all PCR-based validations was to facilitate the RT-PCR
and qPCR primer design and experiments. The amplicons
for the selected AEEs had to be approximately 150bp long
and the candidate exon and its ﬂanking exons should not
contribute to another splicing event. In other words, we
did not cherry-pick the AEEs in order to achieve high
validation rates. All primers were designed using the
command line version of Genome PRIDE (38), and
amplicons were 150bp long. The forward primers were
placed on the alternative exon junctions (S1 and S2
primers), and a single reverse primer was placed in the
respective ﬂanking exon (R1 primers) (Supplementary
Figure S13). Junction primers were positioned on the
junction with a minor 30-overlap (3bp) to ensure ampliﬁ-
cation speciﬁcity. S1 and S2 designs were used for
RT-PCR and qPCR. For 23 CASI cases, S3 primers
were placed in the constitutive, ﬂanking exons and used
only for RT-PCR validation. Primer sequences are
available in Supplementary Tables S2, S5 and S7.
Exon array analysis
cDNA labelling and microarray hybridization were per-
formed as described in GeneChip Whole Transcript
(WT) Sense Target Labeling Assay Manual following
manufacturer’s instructions (P/N 701880 Rev.4, www
.aﬀymetrix.com). All four probes were hybridized onto
the Human Exon 1.0 ST Array (Aﬀymetrix), and
microarrays were scanned with the GeneChip Scanner
3000 7G (Aﬀymetrix). A model-based analysis for tiling
arrays (39) was applied to perform the intrachip normal-
ization, with the adjustment for exon arrays described by
Kapur et al. (40). Quantile normalization was then applied
between arrays (41) with Aﬀy package in BioConductor
(version 2.2) (R statistical environment, v.2.7.0) (42).
Detection call p-values were computed for each probe
set with a paired Wilcoxon signed rank test that
compares probe intensity to control probes of similar
GC content. More precisely, each probe is compared
with the 75% quantile of the set of control probes with
similar GC content. The detection call p-value of a probe
set was calculated using the chip-wise pairing of probe
intensities to control intensities. An exon or gene probe
set was called present when the corresponding FDR cor-
rected p-value was <5% as in Gardina et al. (20). The
probe-to-exon and probe-to-gene assignment was done
using a chip description ﬁle (HsEx10stv2_Hs_ENSE),
based on Ensembl v.46, and provided as R package (43).
Exon and gene expression were deﬁned as the mean over
probe intensities for both replicates.
The isoform predictions were computed with the
MIDAS algorithm of the Aﬀymetrix ExAcT software
version 1.8.0 (44) on normalized values (see below).
MIDAS proceeds in two steps (20,44): (i) attributing a
p-value to each exon indicative of an expression change
between the two conditions, and (ii) attributing a splicing
index (SI) to each exon measuring the amplitude of these
expression changes. The p-values were subsequently cor-
rected using the Benjamini–Hochberg procedure (34) and
the threshold set to 0.2. This threshold was chosen as only
one gene was found with a corrected p-value <0.05. The
threshold for the SI (|SI| 0.5) was set as reported
previously (20). The following ﬁlters were further
applied: (i) the corresponding gene is expressed in both
conditions, (ii) gene expression is higher than the 50%
quantile in both conditions and (iii) the exon is called
present in either one of the two conditions.
RESULTS
A general stochastic count model for transcriptome
analysis
Transcriptome analysis by RNA-Seq allows the direct
detection of both canonical exons as well as alternative
isoforms from sequence reads overlapping splice junctions
(25,27,29). However, junction reads address mostly
splicing events involving internal exons and are inherently
under-represented in a typical dataset. To circumvent
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AEEs by exploiting information provided by the number
of reads within exons.
We used a Poisson-based stochastic count model to
describe transcript abundance. The observed read counts
T originating from a transcript are a realization of a
Poisson distribution whose expected value is proportional
to the transcript length and proportion. Read counts
observed within exons are drawn according to a
multinomial distribution Mð pe ðÞ
n
e¼1,TÞ. The proportion of
reads pe expected in exon e can be deﬁned arbitrarily and
adapted according to the distribution of read coverage
along transcripts (‘Materials and Methods’ section).
In the following, we assumed a uniform distribution of
the reads, such that an exon relative coverage pe is simply
determined by its eﬀective exon length:
pe ¼
le P
e
le
:
The assumption of a uniform distribution of the reads was
veriﬁed on a human dataset (27) that we used in this study
(Supplementary Figure S1), but any general distribution
could be used for a diﬀerent dataset.
Additionally, we veriﬁed that RNA-Seq-measured exon
expression levels in the analysed dataset are accurate and
that no experimental artifacts create atypical, e.g.
bimodal, distributions. We addressed these global issues
by selecting all genes that harbour exons with a large devi-
ation from the mean expression level across the gene. We
expect to see that only a minority of genes have more than
one exon with a clearly deviating mean expression signa-
ture. Indeed, this was the case as <30% of the genes
contain such exons (with a diﬀerence of more than 2 SD
to the mean gene expression level, see Supplementary
Figure S1).
Predicting alternative exon usage based on
sequence read counts
In principle, AEEs can be pinpointed by skewed read
densities in the corresponding exons of a given gene. If
the density of reads over all exons of a given gene is homo-
geneous, after correcting according to expected propor-
tion pe, individual AEEs can be scored based on a
so-called Alternative uSage Index (ASI). The ASI corre-
sponds, for each exon and within a given gene, to the
standardized deviation from the mean expression value.
We generated two indexes that are, respectively, named
(i) CASI and (ii) DASI. It is important to note that the
CASI/DASI can pinpoint any event corresponding to a
variation of exon-level expression like cassette exons,
alternative donor and alternative acceptor splice sites,
alternative start exon and alternative polyadenylation
sites (APSs), but these methods cannot directly infer
which type of AEE occurs. In addition to predicting
AEEs, we designed a method addressing the relative
POEM, based on known transcript structures. The
overall strategy is summarized in Figure 1.
All proposed methods are inﬂuenced by the length of
the diﬀerential exonic region and the diﬀerence in
expression level between the respective transcripts.
Because the majority of ﬁrst-exon events encompass
complete exons, in our model, ﬁrst-exon events behave
similar to skipped-exon events. Alternative isoforms with
APSs as well as alternative 50 or 30-sites aﬀect a single
exon, which leads to a diﬀerential read distribution in
just a part P of the alternative exon. For APSs, the
length of the diﬀerential part P will usually be long, as
30-exons are on average much longer than internal
exons. In case of alternative 50 or 30-sites, the size of part
P will frequently be smaller than the average exon length
thus complicating the detection of the variant.
Prediction of alternative exon usage within one condition
In order to address AEEs inside a given conditions, we
developed the CASI method whose principle works as
follows: we ﬁrst identify genes with a signiﬁcantly diﬀerent
read coverage across exons using Pearson’s chi-square test
(CASI p-value, p 0.05). In the second step, we attribute a
score (CASI) to the individual exons according to their
amplitude of change in expression (Figure 1; see
‘Materials and Methods’ section).
Simulations
In order to analyse the theoretical accuracy of CASI, we
simulated a skipped-exon event with diﬀerent relative
expression levels compared with the constitutive form
and computed sensitivity and speciﬁcity for 1000 repeti-
tions. We also addressed the impact of noise on these
measures (see ‘Materials and Methods’ section). Figure
2A shows the speciﬁcity and sensitivity of CASI predic-
tions with noise. The predictions are very robust with
>80% speciﬁcity, and the sensitivity increases according
to the expression level of the alternative isoform.
Prediction on human RNA-Seq data
After investigating the theoretical properties of the CASI
method, we made predictions on two human cell lines: a
B-cell lymphoma and a HEK293T cell line (27).
We calculated the CASI for all genes expressing at least
two exons in a given cell line (12140 genes in HEK and
10417 genes in B cells). A total of 7991 genes in HEK and
of 6837 genes in B cells showed a signiﬁcant CASI p-value
(see ‘Materials and Methods’ section). Data were ﬁltered
further by imposing a threshold on the CASI  2 to yield
maximal sensitivity (see below). There remained 4459
genes in HEK and 3490 genes in B cells with a signiﬁcant
CASI, for which we predicted 6869 and 5008 AEEs,
respectively. CASI predicted more than one AEE
for 666 and 841 genes in HEK and B cells, respectively.
A total of 2650 AEEs (in 2428 genes) were shared
between HEK and B cells pointing to events common
to very diverse cell types (Supplementary Tables S1A
and S1B).
Sensitivity and bootstrap analysis
A data-based estimate of sensitivity for CASI predictions
was derived for AEEs identiﬁed by reads mapping to
splice junction sequences (see ‘Materials and Methods’
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junctions were predicted by CASI, such that sensitivity
was 100% (Supplementary Figure S4).
In addition, we analysed the quality and the robustness
of CASI predictions. A new bootstrap procedure was
developed to investigate the consistency of predictions
on real data. For each bootstrap sample, we removed
reads from the data that mapped to random positions
inside an exon and recorded the eﬀect on the prediction
of AEEs (‘Materials and Methods’ section). In this
context, a highly uneven read distribution would
signiﬁcantly impact the number of predictions. However,
the predictions are shown to be very robust with <5%
relative error for diﬀerent cut-oﬀ on the CASI values
(Figure 2B and Supplementary Figure S2).
Experimental veriﬁcation
In order to optimize the CASI predictions, we tested a
subset of predicted AEEs by RT-PCR. Though CASI
does not provide indications on the nature of the
detected AEEs, we designed the PCR for testing
exon-skipping events, as it is the most prevalent form of
AS (15). We tested a selection of 61 AEEs (50 in HEK and
11 in B cells), of which >50% had CASI as the sole indi-
cator of an alternative isoform (Supplementary Table S2).
Thirty-ﬁve CASI predictions were validated as true
exon-skipped events, of which 17 were not supported by
junction reads. This emphasizes the power of CASI in
identifying AEEs as illustrated for the third exon of the
NONO gene (Figure 2C). Among the 26 AEEs that could
not be validated, we observed one likely false negative
case, corresponding to a skipped exon in the gene
TCOF1 in HEK supported by only one junction read
(Supplementary Table S2). As the remaining 25 CASI
cases could, in principle, involve alternative donor or
acceptor sites, we examined whether other data sources
(e.g. junction reads, ESTs or ENSEMBL) provided clues
that could infer these types of AS. Indeed, nine exons were
Figure 1. AS analysis workﬂow. (A) RNA-Seq reads are mapped to the reference genome and intersected with exon positions, AEEs are predicted
within a condition (CASI) or two conditions (DASI). POEM estimates splice form proportions within a condition using known transcript structures.
(B) Details of the analysis steps for DASI, CASI and POEM, performed on RNA-Seq data for HEK and B cells. The number of tested genes,
transcripts or exons is reported for each method.
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(Supplementary Table S2) among which four AEEs were
detected by junction reads, such as the usage of an alter-
native acceptor site in the DUS1L gene (Supplementary
Figure S3). Based on these experimental veriﬁcations, the
speciﬁcity of the CASI was estimated to be close to 60%.
Further, we estimated the predictive power of the
procedure by using the receiver operating characteristic
analysis, where each exon tested by RT-PCR (negative
or positive) was associated with its corresponding CASI
value. Based on these PCR results, we obtained a
speciﬁcity of 89% and a sensitivity of 51% for the CASI
method (CASI  4), in line with the genome-wide
estimate of sensitivity deduced by splice junction analysis
(Supplementary Figure S4). The number of false positives
(1 speciﬁcity) cannot be deduced from the mapping of
splice junctions alone, due to the problem of non-unique
spliced alignment matches for short reads and the low
expression of many alternative transcripts. However, the
simulation and bootstrapping results hint to the fact that
the number of false positives is not much higher than
the 11% observed in the PCR experiments on 61 AEEs.
Figure 2. (A) Sensitivity and speciﬁcity (y-axis) for CASI AEE prediction for diﬀerent minor isoform proportions (x-axis) based on simulation by
introducing 20% noise (‘Materials and Methods’ section). (B) Robustness estimation for predictions on HEK data. The change in predicted number
of AEEs is shown relative to the total number of predictions for the whole dataset (y-axis) for 500 bootstrap samples using a CASI of  2. The x-axis
shows the reduction in length that was introduced to an exon at random (p=0.25). (C) RT-PCR validation of a predicted AEE of NONO in HEK
cells (CASI); it shows the observed exon–exon junction (blue arrows) and the corresponding number of reads (above the arrows) for all exons of the
three annotated isoforms (ENSEMBL v.46). S1 and S2 primers are placed on the splice junctions of the constitutive and the skipped forms,
respectively (red dashed line) to uniquely amplify two diﬀerent splice variants of NONO. R1 and S3 primers were designed inside surrounding
exons. Exons not considered in CASI analysis are marked by an asterisk. (D) Agarose gels (1.5%) showing the RT-PCR ampliﬁcation results of
S1-R1, S2-R1 and S3-R1 fragments. The observed sizes of the bands correspond to the expected sizes.
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dicted 2499 AEEs in 2070 genes for HEK and to 1775
AEEs in 1532 genes for B cells, respectively. Seven
hundred and twelve AEEs in 693 genes overlap between
the two cell lines.
It is of particular relevance to compare the respective
performances of CASI versus splice junction reads in their
abilities to detect genes with AEEs. Out of the 3858 genes
predicted to have an AEE by any of these two methods in
HEK cells, only 845 were detected simultaneously by the
CASI and junction reads (Supplementary Figure S5).
Moreover, there are notable qualitative diﬀerences in the
detected AEEs. Splice junction reads revealed a larger
number of internal AS exons (27), whereas most of the
events detected by the CASI targeted terminal exons, par-
ticularly the most 30-exons (Figure 3).
EST-based validation
The signiﬁcant expression variation detected in terminal
exons might reﬂect the presence of multiple APSs, which
are generally poorly annotated in the current databases.
Globally, diﬀerential expression involving the 30-terminal
exon was frequently observed in the human dataset, in
particular in genes annotated for APSs based on an inde-
pendent EST dataset (B cells: 3.3e
 244, HEK cells:
1.6e
 291, hypergeometric p-value; see ‘Materials and
Methods’ section). This is in line with the observations
of Sandberg et al. (45), which showed that a large
fraction of genes in proliferating cell lines express
shortened 30-UTRs. The gene HIP2 reported in the pub-
lication shows the same behaviour (Supplementary Figure
S6). Similarly, CASI 50-terminal exons were more
frequently found in genes annotated for alternative TSS
of the 50 AEEs in HEK and B cells, 67% and 74%,
respectively (5.6e 17 and 4.1e 14, hypergeometric
p-value, see ‘Materials and Methods’ section).
These results illustrate the complementarities between
CASI and junction reads. CASI performed better than
junction reads for identifying rare splice junctions,
whereas junction reads can detect multiple AS events for
complex transcript isoforms where CASI performance is
poor. In terms of AEEs involving internal exons, only
one-fourth of the CASI predictions were corroborated
by junction reads (Supplementary Tables S1A and S1B).
Further, we compared the predicted AEEs (CASI  4)
against a set of 73948 known AEEs in EST data (see
‘Materials and Methods’ section; Supplementary Table
S3). Data indicated that 22% (126 out of 563) of the pre-
dicted internal AEEs in HEK cells and 24% (98 out of
414) in B cells were novel, and that most of these novel
AEEs were cell type speciﬁc (Supplementary Table S3).
Taken together, our data indicate that  30% of the
genes are expressing alternative transcripts in each cell
type. Combining both cell types, 49% of the genes show
alternative isoforms.
Relative proportions of transcript isoforms
Beyond the identiﬁcation of AEEs, one follow-up issue is to
estimate the respective proportions of the various transcript
isoforms. Towards this aim, we designed an algorithm
called POEM, estimating the abundance of each known
isoform, based on a probabilistic model that integrates
the number of reads in exons and the information pertain-
ing to annotated transcripts. In its principle, POEM is com-
parable with prior studies (46,47) interrogating arrays
combining exon and splice junction probes. Here, we
used the EM algorithm to infer non-observed proportions
of the isoforms, with a method similar to the one proposed
for EST analysis (13) (see ‘Materials and Methods’ section
and Supplementary Data).
Simulations
The theoretical accuracy of POEM was assessed by simu-
lations. In each set up, we monitored the mean or
maximum absolute error on a transcript proportion.
First, simulations were performed on a template gene of
1200bp and considering one exon-skipping event. We
varied the length of the skipped exon, the exon inclusion
rate and the gene expression level to assess their impact on
the estimation error rate (Figure 4A). The average error
on proportion estimations decreased with gene expression
level. Furthermore, the error of estimation was inversely
correlated with the length of the skipped exon (Figure 4A,
grey to dark lines). The exon inclusion rate also had an
inﬂuence on the error, as a 20% inclusion rate (Figure 4A,
dashed lines) had constantly higher estimation error than
an 80% inclusion rate (Figure 4A, plain line). A minimum
of 300 reads in the gene achieves a reasonable accuracy for
POEM (Figure 4A).
We then addressed the expected global accuracy of
POEM with a second simulation on all annotated tran-
scripts (Ensembl v.46) and monitored the error made on
proportions as a function of gene expression (Figure 4B,
dashed lines). Two diﬀerent transcripts from ENSEMBL
Figure 3. Distribution of the number of AEEs predicted by CASI and
DASI. Bars show the number of 50- (black), internal (grey) and 30-exons
(white) predicted as AEE within cell lines (CASI  4) and between cell
lines (|DASI| 2). The whiskers for CASI are obtained by shortening
the length of the 50- and 30-exons artiﬁcially by 20% in order to
estimate the error due to the annotation in the 50- and 30-end of a gene.
PAGE 9 OF 15 Nucleic Acids Research, 2010,Vol.38, No. 10 e112Figure 4. (A) Plot showing the 90% quantile of the average error for proportion estimation by POEM based on simulations for one gene with one
exon-skipping event. The average error (y-axis) is calculated according to the number of total reads in the gene (x-axis) and for various skipped exon
lengths: 120bp (light grey), 240bp (grey) or 360bp (black). The average error is shown for a proportion of 20% (dashed lines) and 80% (plain line).
(B) This plot shows the 90% quantile of the mean (circles) and maximum (squares) error (y-axis) for POEM on all annotated ENSEMBL (v.46)
transcripts. (C) Scatter plot showing the correlation (PCC=0.65) of inclusion rates (constitutive forms) on 123 AEEs derived from exon–exon
junction counts (x-axis) and POEM estimations (y-axis). Cross marks denote AEEs in genes with a quality score  14. Dashed lines represent the
20% error margin in (C) and (D). (D) Scatter plot showing the correlation (PCC=0.81) of the inclusion rates on 47 AEEs measured by qPCR
(x-axis) and estimated by POEM for a single exon-skipping event (y-axis). Plus marks denote unannotated AEEs in ENSEMBL v.46. (E) POEM
estimation for annotated transcripts of MPI in HEK cells. Numbers reported on light blue arrows represent the expected counts on exon–exon
junctions according to the estimated proportions with POEM for the three annotated isoforms (ENST000000379693, ENST000000352410 and
ENST000000323744). The proportion estimate for each isoform is shown to the right (in percent). qPCR primers were designed to estimate the
inclusion rate of exon 2 (‘Materials and Methods’ section). The skipping event of exon 3 was not annotated in ENSEMBL v.46, but was supported
by an observed junction read. (F) The bar chart shows the inclusion rate of exon 2 computed by POEM (grey) and measured by qPCR (black) for
HEK and B cells.
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levels (‘Materials and Methods’ section). The 90%
quantile of errors show that, with a minimum of 300
reads within the gene (Figure 4B, vertical line), the
average error is <12.6% (maximum error is <18.6%).
Application to human RNA-Seq data
Based on both simulations, we applied POEM to all genes
with at least 300 reads mapping inside the exons of the
gene and annotated with at least two isoforms indicative
of AS in internal exons (‘Materials and Methods’ section).
In this, we estimated the relative isoform proportions for
830 and 640 genes in HEK and B cells, which were
annotated with 2412 and 1911 transcript variants, respec-
tively. From this set, POEM estimated proportions for
1920 and 1487 transcripts for HEK and B cells, respec-
tively (Supplementary Table S4). We veriﬁed these estima-
tions by (i) analysing the number of reads mapping to
exon–exon junctions and (ii) experimental validations
using qPCR. For instance, Figure 4E shows that the inclu-
sion rate of exon 5 in the gene MPI could be deduced from
the ratio of reads specifying the exon–exon junctions that
is 84% in this case (‘Materials and Methods’ section). We
compared POEM predictions with the information
provided by junction reads for 267 constitutive AEEs
(149 pairs in HEK and 118 pairs in B cells), showing at
least three exon–exon junction counts. On the whole,
POEM agreed well with the estimates deduced from
junction reads, with a correlation coeﬃcient of 0.65 and
an estimated proportion diﬀerence of <20% for 80% of
the events (Figure 4C).
Experimental validation
The comparison of POEM estimates with qPCR measure-
ments for a total of 47 AEEs in both cell lines (22
exon-skipping events, two mutually exclusive events;
‘Materials and Methods’ section) showed a high correla-
tion (PCC=0.81, Figure 4D and Supplementary Table
S5). The gene MPI is an illustrative example (Figure
4E), which is also conﬁrmed by junction reads. Precise
inference of a large diﬀerence in relative expression
levels is hampered if one of the isoforms has a very low
expression value. This is illustrated in Figure 4D, where 13
events (with qPCR AS proportion close to 0% or 100%)
display an expression level diﬀerence of 2–3 orders of mag-
nitude between the constitutive and the skipped form
(Supplementary Table S5).
Figure 5. qPCR validation of a predicted AEE in MKI67 between HEK (blue) and B cell (red) (DASI). (A) Screenshot of the MKI67 gene. The
primers were designed to compare the inclusion rate of exon 7 between HEK cells and B cells. (B) RT-PCR results validate the presence of the
constitutive and the skipped form in both cell lines. For both S1-R1 (constitutive) and S2-R1 (skipped), a PCR product of length 163bp is expected if
the form is expressed, otherwise no band should be visible. (C) Bar charts representing the normalized expression values for the constitutive form
(black) and the skipped form (grey) obtained by qPCR. The results show that the skipped form is more abundant in B cells relative to the
constitutive form, as predicted by the DASI method (DASI=5.2).
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were supported by junction reads. When we compared the
estimated proportions derived from junction reads with
the estimates from qPCR for these 38 AEEs, the correla-
tion was slightly lower (PCC=0.74). This is due to the
paucity of reads identifying junctions, reducing the signi-
ﬁcance of ratios associated with low read counts for
estimating AEEs. Besides, with twice 8 million reads
sequenced, the junction reads depth is still far from satu-
ration, so we expect to see at most 50% of the expected
junctions. Therefore, exploiting the number of counts in
exons oﬀers complementary information in detecting and
quantifying AEEs, in particular when the dataset does not
reach saturation.
Analysis of diﬀerential isoform usage between two
conditions
In order to address AEEs diﬀerentiating between two con-
ditions, e.g. control and disease sample, we developed the
DASI method whose principle works as follows. Brieﬂy,
we ﬁrst identify genes whose relative exon usage diﬀers
signiﬁcantly between two conditions using Fisher’s exact
test (DASI p-value, adjusted p 0.05). Secondly, the indi-
vidual exons are scored (DASI) according to the ampli-
tude of the detected diﬀerential expression (Figure 1;
‘Materials and Methods’ section).
Application to human RNA-Seq data
We applied this procedure to the 9242 genes expressed in
both HEK and B cells (‘Materials and Methods’ section),
leading to the identiﬁcation of 613 genes with a signiﬁcant
DASI p-value ( 5%). After applying a ﬁltering step
(|DASI| 2), we predicted that 968 exons (in 365 genes)
were diﬀerentially used between the two cell types
(Supplementary Table S6), from which the majority
(78%) were internal exons. A total of 161 genes had
more than one diﬀerential AEE between HEK and B cells.
Functional analysis
Analysis of the functional properties of these 365 genes
showed that DASI-predicted genes were enriched for
factors whose molecular functions are involved in transla-
tion and RNA metabolic processes, nucleic acid transport,
ribonucleoprotein complex biogenesis and assembly and
transcriptional regulation. Three transcription factors
(MEF2B, MAZ and SMARCB1) were among the top 20
genes showing the most signiﬁcant DASI p-values. The
best candidate, MEF2B, known to be involved in B-cell
diﬀerentiation (48) showed indeed an alternative TSS in B
cells (Supplementary Figure S7), suggesting the usage of
alternative promoters associated with its speciﬁc function.
Experimental veriﬁcation
We validated a subset of 16 high-scoring DASI events by
qPCR. Comparison of the expression ratios of the skipped
versus constitutive exons between the two cell lines
showed that the DASI predictions and the qPCR results
were concordant, with a validation rate of 69% (consid-
ering a fold change of at least 1.5 for the qPCR)
(Supplementary Table S7). An illustrative example is the
proliferation marker gene MKI67, which is universally
expressed in proliferating cells but almost absent in quies-
cent cells (49). The MKI67 mRNA that contains the large
exon 7 is equally abundant in B cells and HEK cells, but
the skipped form is more highly expressed in B cells than
in HEK cells (Figure 5).
Comparison with exon arrays
Previous attempts, to systematically decipher AEEs
occurring between diﬀerent conditions or tissues, have
made use of exon arrays alone or in combination with
splice junction arrays (6,19,20,50). For comparative
purposes, we interrogated the human Aﬀymetrix exon
chips 1.0ST using the same source of material as well as
one biological replicate (‘Materials and Methods’ section).
For sake of simplicity, we focused the present analysis on
the probe sets corresponding to all exons annotated in
ENSEMBL (‘Materials and Methods’ section), i.e.
149079 exons in 16527 genes. A total of 70 627 exons
(9322 genes) in HEK cells and of 57406 exons (7823
genes) in B cells were found expressed by both
technologies. In terms of detected exons, there was a
good agreement between arrays and RNA-Seq, where
90% of the genes detected by exon chips were also
scored by RNA-Seq. As previously reported (27),
RNA-Seq is more sensitive than arrays, with 26300 and
23866 additional exons detected in HEK and B cells, as
being expressed solely by RNA-Seq.
A total of 51302 exons (in 7210 genes) were detected by
both RNA-Seq and exon arrays in the two cell lines
simultaneously, used as a framework for comparing the
power of the respective technologies in the detection of AS
events. We observed a good correlation (PCC=0.73;
Supplementary Figure S8) between the log-ratio of expres-
sion values for the exons expressed in both cell lines, with
increased correlation for higher expression.
For detecting diﬀerential AS with exon arrays, we used
the standard MIDAS method (20,44) and analysed only
the genes expressed above the 50% quantile of the expres-
sion values in both cell lines (‘Materials and Methods’
section). MIDAS proceeds in two steps, which are
similar to the DASI. Comparison of the DASI results
with MIDAS showed little agreement in the detection of
genes with AEEs between HEK and B cells (10 genes with
16 exons are in common, Supplementary Figure S9). All
genes with predicted AEEs by DASI and MIDAS were
among the most highly expressed ones in both cell lines.
In order to investigate the platform diﬀerences, we
calculated the quadratic mean distance for every gene,
between RNA-Seq and exon arrays, over exon expression
log-ratios (HEK versus B cells). The quadratic mean dis-
tances associated with genes with AEEs predicted by
either DASI only, MIDAS only or by both methods
simultaneously did not show major diﬀerences
(Supplementary Figure S10). The lack of agreement
between the methods reﬂects the fact that the analysis of
alternative isoforms is very sensitive to subtle variations in
expression values that arise both at the individual exon
and whole gene expression level. In this context, a
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requisite for pinpointing variable exons with a reasonable
speciﬁcity. This problem appeared to be less prominent
with RNA-Seq, showing clearly a smaller variation of
expression values across exons of a given gene
(Supplementary Figure S11). The RCC1 gene, for
example, was detected by DASI and validated by qPCR,
but not detected by MIDAS (Supplementary Fig. S12). In
this case, the alternative exon was below the detection
threshold on arrays. Only two of the eight DASI predic-
tions veriﬁed by qPCR were also detected by MIDAS
(genes MDC1 and MKI67).
DISCUSSION
Digital transcriptome analysis using next-generation
sequencing opens up unprecedented possibilities for the
analysis of the dynamics of transcription and transcript
processing, in particular alternative isoforms expressed
within a single tissue or diﬀerentially expressed between
tissues (or physiological conditions). We described here a
set of methods that can infer AEEs from mRNA
sequencing data using short-read sequencing technology.
The proposed approach, combining hypothesis testing and
EM estimation, was evaluated by RT-PCR-based experi-
mental validations and by comparison with exon array
data. As a prerequisite, the principle of the methods
assumes the distribution of reads across transcripts is
known. Whereas possible biases might aﬀect the read dis-
tribution (25,36), we showed that the reads were rather
uniformely distributed in internal exons in the analysed
dataset. However, 50- and 30-terminal exons often
showed deviations mostly due to natural variation
associated with APS and alternative TSS. We ruled out
that biases not accounted in our model could signiﬁcantly
aﬀect our results by applying a bootstrap procedure and
showed that >95% of the predictions remained stable. An
alternative source for nonuniformity might be antisense
transcription in case of an RNA-Seq protocol without
strand information. While we have removed exonic
regions where two genes overlap, still some antisense tran-
scripts may not be represented in current gene annotation.
Read counts of unannotated sense–antisense overlapping
regions will, therefore, be increased artiﬁcially in the
current dataset. Further improvements in protocols for
the RNA-Seq library preparation will help to reduce
read distribution biases (25) and to resolve strand-speciﬁc
expression (51).
For single genes, it is expected that the length of the
variable region between two isoforms will inﬂuence the
detection power of methods using read coverage
(Simulations). For extreme cases aﬀecting only a few
bases of one exon—like NAGNAG sites (15)—those
methods are likely unable to detect these changes. By
design, CASI and DASI have certain biases in detecting
splice variants. While CASI requires in most cases the
existence of at least two transcripts for a gene, DASI is
able to predict variations on single transcripts with only
one transcript in each condition. In contrast to DASI,
exons with low expression are not taken into account by
CASI to avoid, for instance, the inﬂuence of potential
annotation errors. Consequently, CASI predictions are
based on a smaller set of expressed internal exons
compared with DASI predictions.
In their principle, the CASI/DASI strategies could be
paralleled with the type of analysis performed with exon
chips. We showed that using digital information derived
from only  8 million reads sequenced in each condition,
the prediction of AEEs diﬀerentiating HEK from B cells
exhibited higher sensitivity and speciﬁcity than estima-
tions derived from exon chips. We demonstrated that
one of the major problems with arrays is that the large
variation of expression levels across exons of a given gene
adversely aﬀects the detection of AEEs. This problem
adds up to the well-known array issues related to probe
design, cross-hybridization and detection of speciﬁc
signals for genes that are poorly expressed. Here, data
showed that only a small fraction of the qPCR-veriﬁed
AEEs were detected by the exon array.
Previous array-based predictions of AEEs reported a
speciﬁcity of 82–85% and a sensitivity of 49–53% (8,52).
Here, given the actual dataset, CASI alone reached a
speciﬁcity of 89% and a sensitivity of 51%. However, as
we have shown here, the inventory of AEEs is drastically
improved after integration of splice junction reads. Given
that our work was conducted with only  4 millions of
mapped reads per cell line and allowed to estimate
AEEs with largely improved performances as compared
with exon array-based analysis, there is no doubt that an
exhaustive inventory of alternative transcript isoforms will
be made possible via RNA-Seq. Our data show that it is
essential to merge information from junction reads and
predictions from CASI/DASI types of analysis. While
highly expressed genes are associated with a large
number of reads directly identifying the diﬀerent splice
junctions (and will therefore identify a larger set of
splice junctions in these genes), moderately abundant tran-
scripts will, in many cases, show a suﬃcient number of
exonic tags to allow the prediction of AEEs by CASI,
but might not enable the identiﬁcation of reads at splice
junctions. In general, the complexity of AEEs in a given
gene might better be addressed by junction or paired-end
reads, because for exons aﬀected by multiple variations,
the read distribution will be diﬃcult to interpret.
Our data could be exploited for the prediction of the
combinatorics of AEEs associated with the biology of
speciﬁc cell types. Based on the composite analysis of
many cell types, two recent RNA-Seq studies estimated
that >92% of the human genes undergo AS (9,10). In
line with this observation, we show here that in only two
cell types, 49% of the expressed genes exhibit alternative
isoforms. However, it remains to be understood if all these
AEEs are biologically relevant.
In the quantitative estimation of isoform proportions
(POEM), we obtained a good correlation with qPCR
and junction reads. Alternative strategies estimated AEE
inclusion rates directly from the ratio of junction read
counts (9) or read counts from pooled junction and exon
body reads (10). These methods work well for genes with
high coverage, but the EM-based procedure of POEM is
also more accurate for genes with a low coverage. A new
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showed a lower but reasonable correlation of
RNA-Seq-deduced inclusion rates compared with inclu-
sion rates estimated from microarray data (53). In its
current form, POEM relies on a given transcript annota-
tion to estimate isoform proportions. We are currently
investigating the inference of new transcript structures
and their relative proportions from RNA-Seq within the
POEM framework.
Current advances in sequencing technologies are
leading to more and longer reads per experiment. The
resulting increase in sequence coverage will ease AEE
detection by direct observation. The general framework,
provided herein, can be extended to more complex sce-
narios integrating additional types of evidence, such as
splice junction reads or paired-end reads. The strategy
we propose will keep its discriminative power for
low-coverage studies, such as those obtained by
multiplexing diﬀerent samples on the same sequencing
lane.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
The Gene Expression Omnibus accession number for the
exon array data is GSE13474.
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